Bioinformatic analysis showed that the decrease in FUNDC1 was associated with increased ROS signaling and metastasis, particularly in lung cancer, but another study reported elevated FUNDC1 with increased tumor cell proliferation, migration, invasion, and the resulting poor prognosis for breast cancer patients [146,147]. This evidence concerns the gene FUNDC1 and breast carcinoma.